WADA's 2026 Report: A Slowing Testing Curve and a Widening Trust Gap

In December 2026, in Busan, South Korea, WADA struck the gavel to adopt the 2027 World Anti-Doping Code, fixing its entry into force at 1 January 2027 — a hard, non-negotiable date. When I opened the annual report the agency has just released, what made me stop was something else entirely: the testing-volume curve is flattening. In 2026, total samples rose 12.5 percent year on year. In 2026, growth fell to 3.2 percent. The total crept from 288,865 to 297,965 — roughly 9,100 samples. For anyone who reads tables for a living, a curve that climbs while going flat is always more interesting than a record headline. The COVID laboratory taught me that data feels pain — if only we listen. The report arrives exactly as the new rules cycle enters its transition phase. This is a governance document for the global anti-doping system, with a scope that reaches beyond any single sport. It has four main blocks: testing volume and the adverse analytical finding (AAF) rate; the outcome of compliance audits; the financial position; and strategic direction, whose headline is a shift away from traditional athlete drug testing toward investigations and prevention. The testing series runs continuously from 2026 to 2026, long enough to separate signal from noise. Technically, this is the kind of document I still process as a multi-variable problem. To read it correctly, you must split it into three layers: volume, meaning how many samples were collected; composition, meaning where and when they were collected; and detection yield, meaning how many returned an abnormal result. Collapsing all three into a single number is the most common misreading in the field. The first layer shows growth with fading momentum. From 288,865 samples in 2026 to 297,965 in 2026, an addition of roughly 9,100 samples, equal to 3.2 percent growth — less than a quarter of the previous year's pace. Analysts call this the front-load-and-plateau curve: resources are pumped in early to expand capacity, then the operation hits its ceiling. The second layer, the AAF rate, is nearly frozen: 0.77 percent in 2026, 0.80 percent in 2026, 0.78 percent in 2026. The band of movement is about 0.03 percentage points across three years. That is the most robust finding in the entire report. A stable detection rate while testing volume rises carries two possible meanings: an underlying doping prevalence that is relatively fixed, or a system that is targeting better but into a population with equivalent positivity. The data alone cannot distinguish these, and anyone who asserts one with certainty is going beyond the evidence. The third layer, compliance auditing, is where the picture darkens. Average non-conformities fell from 25.5 to 20, which sounds positive. But that figure comes from just nine audits. With a sample that small, the apparent improvement is easily statistical noise. In the opposite direction, testing-related non-conformities rose 11 percent and accounted for 45 percent of all findings, with 23 percent rated critical. The system is closing the paperwork gap while opening up at the very core: sample collection. That is why I do not believe in luck; I believe in the rail each organisation chooses to stand on. Finance is the least discussed and heaviest section. WADA recorded a shortfall of 8.3 million US dollars against budget. The United States has not paid 3.8 million dollars; Russia remains 3.9 million dollars in arrears. Against that, the organisation still posted a net surplus of 1.2 million dollars in the 2026 income year. A large shortfall coexisting with a small surplus signals cost tightening or deferred spending — and both can suppress testing investment in the near term. The genuine bright spot is the investigations arm: more than 250 operations, 88 laboratories dismantled, over 90 tonnes of product seized. These numbers do not measure testing effectiveness, but they do point to a direction. WADA is shifting from a broad-sampling model to an intelligence-led one. An athlete-centred consultation involving more than 600 athletes and representative commissions across more than 60 countries and more than 70 sports signals an effort to build legitimacy for that pivot. For swimming, the picture has its own contour. This is a sport that consumes testing resources heavily: an athlete entered in multiple events can be sampled repeatedly within a single meet, both in and out of competition. When budgets tighten, high-sampling sports feel it first. The risk does not sit at the major championships, where testing density is underwritten by broadcast contracts, but at the bottom: small federations and training bases far from the centres of power, where out-of-competition coverage can thin out before anyone notices. This is where a contrarian read is needed. The report's headline speaks of expanded testing, but the data inside draw a decelerating curve. That mismatch is usually a consequence of choosing the base year. Take 2026 as the anchor and growth looks impressive; take 2026 and it is nearly flat. One string of numbers, two different stories — and readers deserve to know which story they are being told. A second contrarian point concerns faith in the formula that more testing equals more catches. Over three years the detection rate has stood still at roughly 0.78 percent. If volume rises while the detection rate holds, most of the extra volume is flowing into a low-positivity zone, or the system is actively selecting targets in a way that makes the detection rate a poor proxy for true violation rates. Both readings cast doubt on how the industry measures its own effectiveness. A third contrarian point lies in the regulatory gap. The 2027 Code has been adopted but does not take effect until 1 January 2027. Between those two dates sits a transition window of nearly two years. During that window, national anti-doping organisations keep operating under the old standard while preparing for the new one. Past experience suggests such windows see more delay than preparation. The rail behind Risdon leads nowhere — that emptiness tells the whole story better than a finish line. The same holds for the compliance audits in this report. Nine audits cannot paint a system-wide picture, but the very thinness of the evidence reveals that internal oversight capacity remains limited. Every record is a confirmed hypothesis; every failure is an equation waiting to be solved again. For swimming audiences, it is worth remembering that this report contains no performance data at all. No lanes, no distances, no athlete names. Its value is governance context: who is paying, who is in arrears, which rules apply from which date, and which link in the chain is exposed. Assessing an 800 metre women's race belongs to another document; assessing the system that protects that race belongs here. One clarification is needed to avoid misreading the nature of the data. A stable detection rate of 0.78 percent does not mean sport is clean. It means only that, in the specific sample collected, 0.78 percent of results were abnormal. If the sample is drawn from lower-risk settings, an unchanged rate can conceal an entire untested zone. This is the base-rate trap any data journalist must flag whenever the number is cited. On the financial side, the question nobody has asked is what happens if payment delays become routine. Arrears by two major members are not merely an accounting matter; they set a precedent. When a large contributing nation defers its obligation without proportionate sanction, others look at that and recalculate. The Code's enforcement mechanism depends on resources the rule-making body does not fully control. Over the medium term, I expect the investigations model to keep expanding while broad testing plateaus. If that holds, sports such as swimming — where traditional doping control leans heavily on sample density — will have to compensate through internal transparency and long-horizon biological data, such as the athlete biological passport. That route costs less but demands far greater discipline in data collection. What I take from this problem is a method of reading, rather than a moral verdict on an institution. Three facts to remember: 3.2 percent is the growth in testing volume; 0.78 percent is the detection rate holding steady; and 1 January 2027 is the date the new Code takes effect. Those three facts tell a story about a system expanding more slowly, detecting more steadily, and preparing for a new standard while its own wallet leaks. What to watch next season: whether the remaining testing capacity flows toward the lanes least often seen.